StemCells Therapy

MEDIA RELEASE SCIENTISTS MAKE GROUNDBREAKING DISCOVERY OF MUTATION CAUSING GENETIC DISORDER IN HUMANS 1. Scientists at A*STARs Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome[1].

Hamamy syndrome is a rare genetic disorder which is marked by abnormal facial features and defects in the heart, bone, blood and reproductive cells.

Viruses act as tiny piezoelectric generators Viruses, tiny chunks of protein and nucleic acid, have long plagued mankind and its evolutionary ancestors before it. But thanks to the wonders of modern genetic engineering, researchers believe they have finally been able to instill a beneficial purpose in these deadly pests

Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Sophie Mohin smohin@liebertpub.com Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, May 7, 2012The body’s natural inflammatory response is an essential reaction to injury and infection. When acute inflammation escalates out of control, such as in sepsis, it causes nearly 10% of deaths in the U.S. and more than $17 billion in healthcare costs each year.

Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Sophie Mohin smohin@liebertpub.com Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, May 7, 2012 In direct contrast to the increasingly cumbersome and frustrating current model for authoring, editing, reviewing, and publishing scientific literature, Kondziolka et al. have developed an interactive knowledge network, called World Science, that will radically change how scientific knowledge is written, published, and shared. This breakthrough in scientific publishing is featured in an article in the inaugural issue of Disruptive Science and Technology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Sophie Mohin smohin@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, May 14, 2012Disruptive Science and Technology, a new groundbreaking, peer-reviewed journal published by Mary Ann Liebert, Inc., publishers, has officially released its inaugural issue. Spearheaded by Alan J.

The Southern Action on Genetic Engineering (SAGE)-Karnataka, which undertook a jatha to highlight the threat to farmers’ seeds by corporate seed companies, will conclude its awareness campaign by holding a State-level Seed Savers’ convention in Bangalore on May 20 and 21. The two-day convention, which will be held at the NGO Hall, Cubbon Park, will hold deliberations on the threat to Karnataka’s seed sovereignty and highlight the State’s seed diversity. Representative of SAGE-Karnataka V.

Hematoxylin and eosin (H&E) staining of sections of wild-type (top row) and H1 triple-knockout (bottom row) embryoid bodies. After 14 days in rotary suspension culture, the wild-type embryoid bodies showed more differentiated morphologies with cysts forming (black arrows) and the knockout embryoid bodies failed to form cavities (far right)

With some clever genetic engineering but without ever touching a cell or an animal, scientist can remotely control cells using ultrasound, light,and, now, also radio waves. The electromagnetic waves can be used to selectivelyheat up parts of cells and activate a gene to make insulin in mice, according to a recent study published in Science. But why care about radio waves if we have light and ultrasound?Radio waves have a couple distinct advantages over existing techniques.

The Californian Right to Know campaign in support of labeling foods and ingredients produced using genetic engineering looks set for inclusion in the states November ballot, after it attracted nearly a million signatures.

ScienceDaily (May 7, 2012) The cells that slough off from a cancerous tumor into the bloodstream are a genetically diverse bunch, Stanford University School of Medicine researchers have found. Some have genes turned on that give them the potential to lodge themselves in new places, helping a cancer spread between organs

Devangshu Datta: Towards an HIV cure Advances in genetic engineering techniques may finally help us win the battle against this global scourge Devangshu Datta / New Delhi May 04, 2012, 00:53 IST Since AIDS, or acquired immune deficiency syndrome, was identified in 1981, there has been only one medically-certified cure. That occurred under unusual circumstances and it gave researchers an important clue about new ways to attack the disease. Recent advances in genetic engineering techniques have aided in this process

A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cellsso-called induced pluripotent stem (iPS) cellsand found that relatively few genetic changes occur during stem cell conversion by an improved method. The findings, reported in the March issue of Cell Stem Cell, the official journal of the International Society for Stem Cell Research (ISSCR), will be presented at the annual ISSCR meeting in June. “Our results show that human iPS cells accrue genetic changes at about the same rate as any replicating cells, which we don’t feel is a cause for concern,” says Linzhao Cheng, Ph.D., a professor of medicine and oncology, and a member of the Johns Hopkins Institute for Cell Engineering

Public release date: 1-May-2012 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, May 1, 2012Passage of the America Invents Act into law led to the most dramatic changes in the U.S. patent system in 60 years

Public release date: 1-May-2012 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, May 1, 2012Herbal, dietary, and energy or nutritional supplements may offer specific health benefits, but they can also have harmful and even life-threatening effects when combined with commonly used medications. Clinicians need to be aware of and educate their patients about the potential risks of mixing supplements and therapeutic agents, since their interaction can diminish or increase drug levels. This timely topic is explored in a provocative article in Alternative and Complementary Therapies, published by Mary Ann Liebert, Inc.

Public release date: 30-Apr-2012 [ | E-mail | Share ] Contact: Vanessa McMains vmcmain1@jhmi.edu 410-502-9410 Johns Hopkins Medical Institutions A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cellsso-called induced pluripotent stem (iPS) cellsand found that relatively few genetic changes occur during stem cell conversion by an improved method. The findings, reported in the March issue of Cell Stem Cell, the official journal of the International Society for Stem Cell Research (ISSCR), will be presented at the annual ISSCR meeting in June. “Our results show that human iPS cells accrue genetic changes at about the same rate as any replicating cells, which we don’t feel is a cause for concern,” says Linzhao Cheng, Ph.D., a professor of medicine and oncology, and a member of the Johns Hopkins Institute for Cell Engineering

The Obama administration is to unveil its National Bioeconomy Blueprint plan today, reports The New York Times. “The growth of today’s US bioeconomy is due in large part to the development of three foundational technologies: genetic engineering, DNA sequencing, and automated high-throughput manipulations of biomolecules,” the report notes, adding that “tomorrow’s bioeconomy relies on the expansion of emerging technologies such as synthetic biology (the direct engineering of microbes and plants), proteomics (the large-scale study and manipulation of proteins in an organism), and bioinformatics (computational tools for expanding the use of biological and related data), as well as new technologies as yet unimagined.” The report adds that such technologies appear to be moving toward advances in health, bioenergy, biomanufacturing, and environmental clean-up. The report includes five strategies, including some to support research and development, and to encourage translating basic findings into commercial applications

All of the nine classrooms in the science wing at Ossining High School were abuzz last week, with students learning about biodiversity, electromagnetic waves and the solubility curves of potassium nitrate. In the Regents Living Environment class, students had their heads down as they took a unit test on genetic engineering

Public release date: 18-Apr-2012 [ | E-mail | Share ] Contact: Michael Bernstein m_bernstein@acs.org 202-872-6042 American Chemical Society Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That’s the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world’s largest scientific society. The article, by C&EN Senior Editor Lisa M

Published on April 19, 2012 at 3:18 AM Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That’s the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world’s largest scientific society